Mutual of America Capital Management LLC Raises Holdings in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)

Mutual of America Capital Management LLC grew its position in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX – Get Rating) by 5.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,662 shares of the software maker’s stock after buying an additional 916 shares during the period. Mutual of America Capital Management LLC’s holdings in Allscripts Healthcare Solutions were worth $398,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in MDRX. JPMorgan Chase & Co. lifted its position in shares of Allscripts Healthcare Solutions by 87.7% during the 4th quarter. JPMorgan Chase & Co. now owns 7,467,089 shares of the software maker’s stock valued at $137,767,000 after buying an additional 3,488,947 shares during the last quarter. Invesco Ltd. lifted its holdings in Allscripts Healthcare Solutions by 86.6% during the 4th quarter. Invesco Ltd. now owns 2,227,469 shares of the software maker’s stock worth $41,097,000 after purchasing an additional 1,033,924 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Allscripts Healthcare Solutions by 15.9% during the 4th quarter. Goldman Sachs Group Inc. now owns 3,427,095 shares of the software maker’s stock worth $63,229,000 after purchasing an additional 469,894 shares in the last quarter. State Street Corp lifted its holdings in Allscripts Healthcare Solutions by 6.0% during the 4th quarter. State Street Corp now owns 4,311,336 shares of the software maker’s stock worth $79,544,000 after purchasing an additional 242,824 shares in the last quarter. Finally, Hillsdale Investment Management Inc. purchased a new stake in Allscripts Healthcare Solutions during the 1st quarter worth about $5,349,000.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on MDRX. StockNews.com cut Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Friday, May 13th. The Goldman Sachs Group initiated coverage on Allscripts Healthcare Solutions in a report on Tuesday, July 12th. They issued a “neutral” rating and a $21.00 price target on the stock. TheStreet cut Allscripts Healthcare Solutions from a “b” rating to a “c” rating in a report on Friday, May 6th. Finally, Piper Sandler lowered their price target on Allscripts Healthcare Solutions from $19.00 to $17.00 in a report on Thursday, June 9th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.33.

Insider Buying and Selling

In related news, Director Paul Black sold 60,000 shares of the firm’s stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $16.58, for a total transaction of $994,800.00. Following the transaction, the director now directly owns 1,254,631 shares in the company, valued at approximately $20,801,781.98. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, insider Thomas Langan sold 51,537 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Tuesday, May 10th. The stock was sold at an average price of $18.12, for a total value of $933,850.44. Following the sale, the insider now directly owns 139,912 shares in the company, valued at approximately $2,535,205.44. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Paul Black sold 60,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $16.58, for a total value of $994,800.00. Following the completion of the sale, the director now owns 1,254,631 shares in the company, valued at $20,801,781.98. The disclosure for this sale can be found here. Insiders have sold a total of 318,015 shares of company stock worth $5,550,054 in the last ninety days. 2.29% of the stock is owned by insiders.

Allscripts Healthcare Solutions Price Performance

Shares of Allscripts Healthcare Solutions stock opened at $15.82 on Monday. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $1.84 billion, a PE ratio of 14.13, a price-to-earnings-growth ratio of 1.38 and a beta of 1.03. The business’s 50-day moving average price is $15.66 and its 200-day moving average price is $18.88. Allscripts Healthcare Solutions, Inc. has a 12 month low of $13.05 and a 12 month high of $23.25.

Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) last announced its quarterly earnings data on Thursday, May 5th. The software maker reported $0.09 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.04). Allscripts Healthcare Solutions had a net margin of 11.60% and a return on equity of 10.97%. The firm had revenue of $142.70 million for the quarter, compared to the consensus estimate of $139.67 million. During the same quarter last year, the company posted $0.13 earnings per share. Allscripts Healthcare Solutions’s revenue for the quarter was up 6.7% compared to the same quarter last year. Sell-side analysts forecast that Allscripts Healthcare Solutions, Inc. will post 0.67 EPS for the current fiscal year.

About Allscripts Healthcare Solutions

(Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

• Get a free copy of the StockNews.com research report on Allscripts Healthcare Solutions (MDRX)
• Use These To Find Your Stock’s Support and Resistance Levels
• Is Boeing Stock is Ready for Lift-Off ?
• Elon Musk is Out, But Should You Be In Twitter Stock?
• 3 Earnings Announcements That Could Surprise
• Twitter’s Up For Third Week In A Row: What’s Next For The Stock?

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX – Get Rating).

Want More Great Investing Ideas?